Professor, Program in Molecular Medicine; Herman G. Berkman Chair in Diabetes Care Innovation; Co-Founder, UMass Cancer Avatar Institute, UMass Chan Medical School
Research Focus - Humanized Mice as Preclinical Models of Human Cancer
Analyzing preclinical models of the interactions between the human immune system and human cancer
Understanding how human tumors escape immune rejection
Developing approaches to modulate the tumor immune environment
Examining newly emerging checkpoint inhibitors for human cancer therapy
Representative Publication
Wang M, Yao LC, Cheng M, et al. Humanized mice in studying efficacy and mechanisms of PD-1 targeted cancer immunotherapy. FASEB J. 2018;32(3):1537-1549.
Six new endowed chairs named at UMass Chan Medical School
These highly accomplished faculty members have been appointed to endowed chairs at UMass Chan Medical School: Dale L. Greiner, PhD; Danny G. Winder, PhD; Elinor K. Karlsson, PhD; Jeannette M. Wolfe, MD; J. Kevin Donahue, MD; and John E. Harris, MD, PhD’05.
Read more
, Graduate School of Biomedical Sciences, School of Medicine, Dermatology, Emergency Medicine, Medicine, Cancer Center, Faculty, Education, Dale L. Greiner, John Harris, Neurobiology, Greiner Lab, Program in Molecular Medicine, Elinor Karlsson, Latest News, Top Stories,
UMass Medical School joins JDRF Center of Excellence in New England to advance type 1 diabetes research
Five UMass Medical School scientists from the UMass Diabetes Center of Excellence are part of the JDRF Center of Excellence in New England that launched Feb. 23. The goal of the is to create a cell replacement therapy that could treat and potentially cure type 1 diabetes.
Read more
, Graduate School of Biomedical Sciences, School of Medicine, Medicine, Michael Brehm, Dale L. Greiner, Greiner Lab, Program in Molecular Medicine,